Search results for "OBESITY"

showing 10 items of 1833 documents

Clinical impact of diabetes mellitus in patients hospitalized for myocardial infarction

2020

Abstract Background Diabetes mellitus (DM) represents a major cardiovascular risk factor for coronary artery disease and myocardial infarction (MI). Purpose We aimed to assess in-hospital events and time trends in MI patients with and without DM between 2005 and 2016 in Germany. Methods The nationwide German inpatient sample 2005–2016 was used for statistical analysis (source: Research Data Center (RDC) of the Federal Statistical Office and the Statistical Offices of the federal states, DRG Statistics 2005–2016, own calculations). Hospitalized MI patients were stratified for the presence of DM and the impact of DM on in-hospital events was investigated. Results A total of 3,307,703 patients…

medicine.medical_specialtybusiness.industryAtrial fibrillationmedicine.diseaseComorbidityObesityThrombosisPneumoniaInternal medicineDiabetes mellitusmedicineMyocardial infarctionCardiology and Cardiovascular MedicineHemostatic functionbusinessEuropean Heart Journal
researchProduct

EP1168 The influence of obesity on tumor recurrence in vulvar cancer patients

2019

Introduction/Background Obesity is associated with decrased survival in several cancer entities. The influence of obesity on prognosis of vulvar cancer patients is not clear. However, knowledge about this may have consequences on treatment and follow-up. Methodology This is an analysis of the large AGO-CaRE-1 study which included vulvar cancer patients (UICC stage IB and higher), treated in 29 cancer centers between 1998 and 2008, in order to analyze treatment patterns and prognostic factors. Results In total, 849 eligible patients were divided into two groups depending on their body mass index (BMI, 0.05). Radical vulvectomies were performed more frequently in patients having a BMI ≥30 kg/…

medicine.medical_specialtybusiness.industryCancerSubgroup analysisVulvar cancermedicine.diseaseObesityTumor recurrenceTime to recurrenceInternal medicineMedicineIn patientbusinessBody mass indexePoster
researchProduct

The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study

2020

Abstract Background Cardiovascular disease (CVD) is currently one of the leading cause of mortality in the European Union. Well-established, modifiable cardiovascular (CV) risk factors include hypertension (HTN), hypercholesterolaemia, diabetes mellitus (DM), obesity, low activity levels, poor diet and smoking. There are no current estimates on the prevalence of CV risk factors among Polish patients solely in the primary care setting. Methods A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the 4th quarter of 2015 and 1st and 2nd quarters of 2016. 438 primary care physicians enrolled 13,724 adult patients that sought medical care for any medical reason in pri…

medicine.medical_specialtybusiness.industryCholesterolDiseaseOverweightmedicine.diseaseObesitychemistry.chemical_compoundBlood pressurechemistryDiabetes mellitusInternal medicineEpidemiologymedicinemedia_common.cataloged_instancemedicine.symptomEuropean unionCardiology and Cardiovascular Medicinebusinessmedia_commonEuropean Heart Journal
researchProduct

Spanish consensus on the physical health of patients with depressive disorders

2014

Comorbidity between depression and physical illnesses is very common and has a significant impact on the health and management of the patient. With the support of the Sociedades Espanolas de Psiquiatria y Psiquiatria Biologica, and Sociedad Espanola de Medicos de Atencion Primaria (SEMERGEN) a consensus was prepared on physical health in patients with depression and is summarized in the present work. The literature review highlighted the high frequency of cardiovascular and endocrine-metabolic disorders in patients with depression such as diabetes and obesity, thus making the primary and secondary prevention recommendations for patients with cardiovascular or metabolic risk applicable to pa…

medicine.medical_specialtybusiness.industryChronic painPrimary care physicianPhysical healthGeneral Medicinemedicine.diseaseObesityComorbidityTherapeutic approachDiabetes mellitusmedicinePsychiatrybusinessDepression (differential diagnoses)Revista de Psiquiatría y Salud Mental (English Edition)
researchProduct

Combining Body Mass Index With Measures of Central Obesity in the Assessment of Mortality in Subjects With Coronary Disease

2013

Objectives This study sought to assess the mortality risk of patients with coronary artery disease (CAD) based on a combination of body mass index (BMI) and measures of central obesity. Background In CAD patients, mortality has been reported to vary inversely with BMI (“obesity paradox”). In contrast, central obesity is directly associated with mortality. Because of this bi-directional relationship, we hypothesized that CAD patients with normal BMI but with central obesity would have worse survival compared with subjects with other combinations of BMI and central adiposity. Methods We included 15,547 participants with CAD who took part in 5 studies from 3 continents. Multivariate stratified…

medicine.medical_specialtybusiness.industryConfoundingHazard rationutritional and metabolic diseasesmedicine.diseaseObesityConfidence intervalCoronary artery diseaseWaist–hip ratioEndocrinologyInternal medicinemedicinecardiovascular diseasesCardiology and Cardiovascular MedicinebusinessBody mass indexCohort studyJournal of the American College of Cardiology
researchProduct

Effects of long-term lifestyle and high-intensity interval training intervention on blood pressure reduction in patients with abdominal obesity

2013

Purpose: The aims of this study were: 1) to study the impact of a combined long-term lifestyle and high-intensity interval training (HIIT) intervention on blood pressure (BP) in patients with abdominal obesity; 2) To document BP reduction responses according to the European Society of Hypertension BP classification. Methods: 105 patients with abdominal obesity (age: 53±10 yrs; 32 men; waist circumference (WC): 112±13cm; systolic/diastolic (SBP/DBP): 133±13/82±8 mmHg; 11% diabetics, 11% smokers, 68% with antihypertensive therapy) were retrospectively analyzed before and after a combined long-term lifestyle and HIIT program twice a week. Anthropometric measurements, cardiometabolic risk facto…

medicine.medical_specialtybusiness.industryDiastoleInterval trainingSurgeryBlood pressureWeight lossInternal medicineHeart rateCardiologyMedicinemedicine.symptomSystoleCardiology and Cardiovascular MedicinebusinessHigh-intensity interval trainingAbdominal obesityEuropean Heart Journal
researchProduct

The burden of disease in Spain: Results from the Global Burden of Disease 2016

2018

Abstract Background and objectives The global burden of disease (GBD) project measures the health of populations worldwide on an annual basis, and results are available by country. We used the estimates of the GBD to summarise the state of health in Spain in 2016 and report trends in mortality and morbidity from 1990 to 2016. Material and methods GBD 2016 estimated disease burden due to 333 diseases and injuries, and 84 risk factors. The GBD list of causes is hierarchical and includes 3 top level categories, namely: (1) communicable, maternal, neonatal, and nutritional diseases; (2) non-communicable diseases (NCDs), and (3) injuries. Mortality and disability-adjusted life-years (DALYs), ris…

medicine.medical_specialtybusiness.industryDisease030204 cardiovascular system & hematologymedicine.diseaseObesity03 medical and health sciences0302 clinical medicineYears of potential life lostEnvironmental healthEpidemiologymedicineDementia030212 general & internal medicineRisk factorbusinessDisease burdenCause of deathMedicina Clínica (English Edition)
researchProduct

Importancia de la dislipidemia en la enfermedad cardiovascular: un punto de vista

2015

The authors present their view on the prevention of cardiovascular diseases, accepting the European ESC/EAS guidelines. They consider that the aim of the lipid control, based on LDL-C goals, is essential for the prevention and treatment of cardiovascular diseases. In subjects with metabolic syndrome (mainly, abdominal obesity, pre-diabetes and diabetes), the primary objective should be apoB or Non-HDL-C, which are better associated with cardiovascular risk. The treatment must be lifestyle changes and control of other risk factors. After calculating cardiovascular risk, statins are the first therapeutic step, with the strength and dose needed to achieve LDL-C goals. If targets are not achiev…

medicine.medical_specialtybusiness.industryDiseaseArteriosclerosismedicine.diseaseEzetimibeAge groupsDiabetes mellitusInternal medicinemedicinelipids (amino acids peptides and proteins)Pharmacology (medical)Lipid controlmedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessAbdominal obesitymedicine.drugClínica e Investigación en Arteriosclerosis
researchProduct

Inconsistency in circulating irisin levels: what is really happening?

2014

The discovery of irisin as a novel and promising peptidic hormone for the treatment of obesity and diabetes has recently been reported. As a result, great hopes have been raised based on this finding, hypothesizing that irisin might provide additional benefits, not only for obesity and diabetes, but also for a wide range of pathological conditions requiring therapeutical and clinical attention. However, controversial results and conclusions on circulating irisin concentrations and correlations with other variables, including its role in metabolism, have recently been reported. Although laboratory assessment of irisin by ELISA is easily available and may provide interesting information for t…

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismBiochemistry (medical)Clinical BiochemistryGeneral MedicineBiochemistryFibronectinsClinical PracticeEndocrinologyEndocrinologyInternal medicineMyokinemedicineDiabetes MellitusHumansObesitybusinessExerciseHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
researchProduct

The follow-up of dietary treatment of obesity

2008

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismBiochemistry (medical)OBESITY TREATMENT DIET SAFETY EFFICACYGeneral Medicinemedicine.diseaseObesityDietary treatmentInternal medicineDrug DiscoverymedicineImmunology and Allergybusiness
researchProduct